Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan McGovern

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical and Translational Radiation Oncology|April 17, 2018
Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapyBrad J Greenfield, Sergio Jaramillo, Mirna Abboud, et al.
World Neurosurgery|May 15, 2020
Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total ResectionChidinma P Anakwenze, Susan McGovern, Nicolette Taku, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2024
Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck MalignanciesAdam J Grippin, Andrew Kim, Yufei Liu, et al.
Neuro-Oncology Practice|May 13, 2024
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approachesThomas H Beckham, Michael K Rooney, Mary F McAleer, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
The Lancet. Oncology|July 9, 2017
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trialAnita Mahajan, Salmaan Ahmed, Mary Frances McAleer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain MetastasesThomas H Beckham, Stephanie O Dudzinski, Michael K Rooney, et al.
JAMA Oncology|June 18, 2025
Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical TrialDebra Nana Yeboa, Jing Li, Ruitao Lin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical and Translational Radiation Oncology|April 17, 2018
Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapyBrad J Greenfield, Sergio Jaramillo, Mirna Abboud, et al.
World Neurosurgery|May 15, 2020
Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total ResectionChidinma P Anakwenze, Susan McGovern, Nicolette Taku, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2024
Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck MalignanciesAdam J Grippin, Andrew Kim, Yufei Liu, et al.
Neuro-Oncology Practice|May 13, 2024
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approachesThomas H Beckham, Michael K Rooney, Mary F McAleer, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
The Lancet. Oncology|July 9, 2017
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trialAnita Mahajan, Salmaan Ahmed, Mary Frances McAleer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain MetastasesThomas H Beckham, Stephanie O Dudzinski, Michael K Rooney, et al.
JAMA Oncology|June 18, 2025
Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical TrialDebra Nana Yeboa, Jing Li, Ruitao Lin, et al.
Pageof 2